Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| REVENUES | $ 60,531 | $ 65,163 | $ 24,643 | $ 196,875 |
| COSTS AND EXPENSES | ||||
| Cost of goods sold | 732,496 | 509,688 | 1,394,641 | 811,694 |
| Sales and marketing | 1,646,942 | 1,126,861 | 2,819,565 | 2,204,693 |
| Research and development | 3,675,716 | 2,857,179 | 7,736,253 | 5,762,807 |
| General and administrative | 1,430,332 | 1,263,137 | 3,809,495 | 2,529,797 |
| Total Costs and Expenses | 7,485,486 | 5,756,865 | 15,759,954 | 11,308,991 |
| LOSS FROM OPERATIONS | (7,424,955) | (5,691,702) | (15,735,311) | (11,112,116) |
| OTHER INCOME (EXPENSE) | ||||
| Interest income | 377,533 | 369,804 | 644,146 | 481,892 |
| Government grant income | 34,814 | 248,373 | 34,814 | 658,546 |
| Foreign currency exchange (loss) gain | (683,434) | 1,285,261 | (281,024) | 1,159,493 |
| Interest expense | 0 | (712) | 0 | (4,170) |
| Change in fair value of convertible notes (related party) | 89,900 | (3,590,600) | (8,172,700) | (3,895,000) |
| Change in fair value of warrant liabilities | 96,398 | (226,249) | (428,125) | (261,932) |
| Other expense | (15,310) | (7,199) | (15,310) | (9,799) |
| Total Other Income (Expense) | 43,194 | (2,103,620) | (9,403,461) | (2,029,237) |
| NET LOSS | $ (7,381,761) | $ (7,795,322) | $ (25,138,772) | $ (13,141,353) |
| NET LOSS PER SHARE: | ||||
| Basic (in dollars per share) | $ (0.02) | $ (0.02) | $ (0.08) | $ (0.04) |
| Diluted (in dollars per share) | $ (0.02) | $ (0.02) | $ (0.08) | $ (0.04) |
| WEIGHTED AVERAGE SHARES OUTSTANDING | ||||
| Basic (in shares) | 340,251,459 | 320,381,058 | 330,652,571 | 296,574,416 |
| Diluted (in shares) | 344,664,661 | 320,381,058 | 330,652,571 | 296,574,416 |
| Options Held [Member] | ||||
| OTHER INCOME (EXPENSE) | ||||
| Change in fair value of derivative | $ 199,536 | $ (182,298) | $ (1,129,019) | $ (158,267) |
| Derivative [Member] | ||||
| OTHER INCOME (EXPENSE) | ||||
| Change in fair value of derivative | $ (56,243) | $ 0 | $ (56,243) | $ 0 |
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of convertible debt. No definition available.
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer and net of reversal, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in income from government assistance, classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|